67 post-doc-image-engineering-computer-vision Postdoctoral positions at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
United Kingdom Application Deadline 9 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
, disease modelling, behaviour, chemogenetics and in vivo neural imaging technologies. The Headache Group is part of the WSPaRC, with broad expertise in sensory biology (pain, vision & hearing) and
-
project, an ambitious programme developing medical-grade nanoneedle bandages to deliver life-changing gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB). This is a unique
-
of genome organisation and metabolic control—with the bold vision of building synthetic life. In this role, you will develop and apply computational methods to analyse single-cell modalities, focusing on gene
-
Application Deadline 16 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
United Kingdom Application Deadline 12 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
manuscript within the lifetime of the appointment. Advanced microscopy, cutting-edge biophysical techniques and genetically engineered mouse models will be used. The labs are well-established and located in
-
United Kingdom Application Deadline 9 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
United Kingdom Application Deadline 31 Aug 2025 - 00:00 (UTC) Type of Contract Other Job Status Part-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
high content imaging, multimodality in vivo imaging, proteomics, spatial and single-cell transcriptomics. As part of King’s Health Partners, we have an excellent environment for basic-clinical